Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 41 non-cytoplasmic 42 62 transmembrane 63 70 cytoplasmic 71 88 transmembrane 89 93 non-cytoplasmic 94 114 transmembrane 115 132 cytoplasmic 133 150 transmembrane 151 161 non-cytoplasmic 162 182 transmembrane 183 210 cytoplasmic 211 231 transmembrane 232 250 non-cytoplasmic 251 276 transmembrane 277 282 cytoplasmic 283 302 transmembrane 303 307 non-cytoplasmic 308 327 transmembrane 328 347 cytoplasmic 348 369 transmembrane 370 424 non-cytoplasmic 425 444 transmembrane 445 459 cytoplasmic
Input: >CA265_RS08855 MNVKFRLTIMSFMQFFVWAAWLITIANYWFGTKQWDGADFGIIFSTMGIASLFMPTITGI LADKWINAERLYAILHILYAATMFYLPQVEDPHTFFWVILVAMCFYMPTIALSNSISYTT LKNGNFDVVKNFPPIRVWGTVGFIAAMWLTNLTGNKASANQFYIAGVSALMLGLYSFTLP ACKPLNLISEKKTFAQKLGLESFKLFADYKMALFFIFSMFLGAALQLTNAYGDVFLDEFK LFPVFAESFVIRYSTIILSISQISETLFILAIPFFLKRFGIKWVIAIAMFAWVLRFGLFA FGDPSTNLWMIITSCIVYGMAFDFFNISGSLFVETSTTPKTRSSAQGLFMMMTNGFGAVF GSLVSGWMINKYFTTYYSSIDSLSKYVKSEADNKHLLQFLKNKGISVLENGNLSRALDVK DWHNIWLSFTIYVLVIAIVFVVIFKHKHTRAEVEAINHL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server